NUWE — Nuwellis, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1506492 ·
Last close
$1.74
Market Cap
$160.4K
52W High
$40.60
52W Low
$1.61
ADV30
4,697,502
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,403,000 | 1,684,000 | -4,568,000 | -4,541,000 | 6,961,000 | 2,083,000 | 4,292,000 |
| Dec 2025 | 2,424,000 | 1,654,000 | -2,443,000 | -2,422,000 | 6,118,000 | 1,085,000 | 3,488,000 |
| Sep 2025 | 2,217,000 | 1,445,000 | -2,697,000 | 468,000 | 7,984,000 | 3,094,000 | 4,070,000 |
| Jun 2025 | 1,725,000 | 958,000 | -2,906,000 | -12,553,000 | 9,200,000 | 4,450,000 | 18,155,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,386,000
Investing CF
$-374,000
Financing CF
$11,335,000
CapEx
$-241,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-64.00
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-320,853,000
Inventory
$1,779,000
Receivables
$1,559,000
ST Investments
—
EBIT TTM
$-8,518,000
Pretax Income TTM
$-19,044,000
Interest Exp TTM
$10,553,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,769,000
EBITDA
$-12,449,000
Free Cash Flow
$-13,435,375
Enterprise Value
$-1,469,161
Total Cash
$2,083,000
Total Debt
$265,000
Shares Out
92,201
Trailing EPS
$47.25
Book Value
$35.34
ROE
-609.4%
ROA
-112.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,270,000 | -11,106,000 | -17,521,000 | 6,118,000 | 3,488,000 | — | -10,810,000 |
| Dec 2024 | 8,740,000 | -10,988,000 | -11,165,000 | 9,864,000 | 3,334,000 | — | -9,591,000 |
| Dec 2023 | 8,864,000 | -17,630,000 | -20,209,000 | 9,770,000 | 6,559,000 | — | -17,937,000 |
| Dec 2022 | 8,543,000 | -17,171,000 | -14,525,000 | 24,673,000 | 12,316,000 | — | -15,149,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.59
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ENDV | ENDONOVO THERAPEUTICS, INC. | $180.8K | $0.00 | — |
| SIGY | Sigyn Therapeutics, Inc. | $135.0K | $0.03 | — |
| EMED | Electromedical Technologies, Inc | $373.2K | $0.00 | — |
| LGMK | LogicMark, Inc. | $460.6K | $0.51 | — |
| RBOT | Vicarious Surgical Inc. | $472.8K | $0.07 | — |
News headlines (Yahoo Finance, 1h cache)
Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
2026-07-31 12:39 · Yahoo
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
2026-07-30 12:00 · Yahoo
Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin
2026-07-28 12:00 · Yahoo
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth
2026-07-27 12:30 · Yahoo
Nuwellis’ new CEO on building a strong foundation for sustainable value creation
2026-07-27 12:11 · Yahoo
Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies
2026-07-16 12:30 · Yahoo
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
2026-07-07 12:00 · Yahoo
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)
2026-06-26 12:00 · Yahoo
Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations
2026-06-25 12:30 · Yahoo
Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders
2026-06-24 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.